Skip to content
healthcare.dev

Livmarli

NDC 79378-210, maralixibat chloride, tablet, from Mirum Pharmaceuticals Inc..

Product NDC
79378-210
Status
Listed
Labeler
Mirum Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219485
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79378-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MARALIXIBAT CHLORIDE10 mg/1

Pharmacologic classes

Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]; Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]

Package NDCNDC-11Package
79378-210-30793780210301 BOTTLE in 1 CARTON (79378-210-30) / 30 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/64000394-1ef6-4e76-8ba8-11f25ba1b167

Use it

Look up 79378-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79378-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79378-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.